Panthera
Phase 1 Terminated
2 enrolled
Lithium
Phase 1 Terminated
2 enrolled
Methadone Hydrochloride as First-Line Therapy in Treating Patients With Chronic Neuropathic Cancer Pain
Phase 1 Terminated
8 enrolled
Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell Transplantation
Phase 1 Terminated
8 enrolled
Fenretinide in Children With Recurrent/Resistant ALL, AML, and NHL
Phase 1 Terminated
3 enrolled
Phase I Trial of IV Fenretinide (4-HPR) Plus IV Safingol for Patients With Relapsed Malignancies
Phase 1 Terminated
16 enrolled
SPOC2013-001
Phase 1 Terminated
4 enrolled
Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
Phase 1 Terminated
35 enrolled 28 charts
Oncolytic HSV-1716 in Treating Younger Patients With Refractory or Recurrent High Grade Glioma That Can Be Removed By Surgery
Phase 1 Terminated
2 enrolled
Liposomal Daunorubicin in Treating Patients With HIV-Related Kaposi's Sarcoma
Phase 1 Terminated
14 enrolled
S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer
Phase 1 Terminated
14 enrolled
Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal Cancer
Phase 1 Terminated
45 enrolled
Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer
Phase 1 Terminated
S0429: Docetaxel, Cetuximab, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer
Phase 1 Terminated
24 enrolled 10 charts
High-Dose 3-Dimensional Conformal Radiation Therapy in Treating Patients With Inoperable Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer
Phase 1 Terminated
14 enrolled
MK0752 in Treating Young Patients With Recurrent or Refractory CNS Cancer
Phase 1 Terminated
33 enrolled
Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors
Phase 1 Terminated
19 enrolled
Carmustine Implants and O(6)-Benzylguanine in Treating Children With Recurrent Malignant Glioma
Phase 1 Terminated
3 enrolled
SU5416 in Treating Children With Recurrent or Progressive Brain Tumors
Phase 1 Terminated
33 enrolled